Literature DB >> 18190262

Infection of hamsters with historical and epidemic BI types of Clostridium difficile.

Nadia Razaq1, Susan Sambol, Kristin Nagaro, Walter Zukowski, Adam Cheknis, Stuart Johnson, Dale N Gerding.   

Abstract

BACKGROUND: North American and European hospitals have reported outbreaks of Clostridium difficile-associated disease with unexpectedly high mortality caused by a newly recognized group of C. difficile strains, group BI. Our objective was to compare, in hamsters, the virulence of a historical nonepidemic BI type, BI1, with that of 2 recent epidemic BI types, BI6 and BI17, and with that of 2 standard toxigenic strains, K14 and 630.
METHODS: For each strain, 10 hamsters were given 1 dose of clindamycin, followed 5 days later with 100 C. difficile spores administered by gastric inoculation. Outcomes were recorded.
RESULTS: The hamster model demonstrated variations in mean times from inoculation to death (for BI6, 40 h; for BI1, 48 h; for K14, 49 h; for BI17, 69 h; for 630, 102 h; for BI6, BI1, and K14 vs. 630, P< .01; for BI17 vs. 630, P< .05) and from colonization to death (for BI1, 7 h; for BI17, 13 h; for BI6, 16 h; for K14, 17 h; for 630, 52 h; for BI1, BI17, BI6, and K14 vs. 630, P< .01).
CONCLUSION: Group BI strains were not more rapidly fatal than the standard toxinotype 0 strain K14 but were more rapidly fatal than the standard toxinotype 0 strain 630. BI6, the most common BI type in our collection, was particularly virulent in hamsters, consistently causing death within 48 h of inoculation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18190262     DOI: 10.1086/523106

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance.

Authors:  Robert A Britton; Vincent B Young
Journal:  Trends Microbiol       Date:  2012-05-15       Impact factor: 17.079

2.  Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile.

Authors:  Adrianne N Edwards; Kathryn L Nawrocki; Shonna M McBride
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

3.  Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.

Authors:  Trevor D Lawley; Simon Clare; Alan W Walker; David Goulding; Richard A Stabler; Nicholas Croucher; Piero Mastroeni; Paul Scott; Claire Raisen; Lynda Mottram; Neil F Fairweather; Brendan W Wren; Julian Parkhill; Gordon Dougan
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  In vitro and in vivo characterization of CB-183,315, a novel lipopeptide antibiotic for treatment of Clostridium difficile.

Authors:  Carmela T M Mascio; Lawrence I Mortin; Karen T Howland; Andrew D G Van Praagh; Shuxin Zhang; Anu Arya; Cun Lan Chuong; Chunfeng Kang; Tongchuan Li; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

5.  A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.

Authors:  Natalie G Anosova; Leah E Cole; Lu Li; Jinrong Zhang; Anna M Brown; Sophia Mundle; Jianxin Zhang; Satyajit Ray; Fuqin Ma; Pierre Garrone; Nicola Bertraminelli; Harry Kleanthous; Stephen F Anderson
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

6.  Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.

Authors:  Peter Warn; Pia Thommes; Abdul Sattar; David Corbett; Amy Flattery; Zuo Zhang; Todd Black; Lorraine D Hernandez; Alex G Therien
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

7.  Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.

Authors:  Jordi M Lanis; Soumitra Barua; Jimmy D Ballard
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

8.  Characterisation of Clostridium difficile strains isolated from Groote Schuur Hospital, Cape Town, South Africa.

Authors:  B Kullin; T Brock; N Rajabally; F Anwar; G Vedantam; S Reid; V Abratt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-27       Impact factor: 3.267

9.  Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1.

Authors:  David Goulding; Harold Thompson; Jenny Emerson; Neil F Fairweather; Gordon Dougan; Gill R Douce
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.